Another study with lupus-prone B6.Sle1.Yaa mice showed that treatment with an anti-IL-21 blocking antibody reduced titers of autoantibodies, decreased renal infiltrating TFH cells and delayed the progression of glomerulonephritis [73]. The gene discussed is IL21; the disease is systemic lupus erythematosus.